1. VNDA to present at three investor conferences in September 2025. 2. Investor presentations on September 3, 4, and 9. 3. Participation may enhance visibility and investor interest in VNDA. 4. Live access to presentations available on Vanda's corporate website. 5. Focus on high unmet medical needs in biopharmaceuticals outlined.
VNDA's conference participation could attract investor attention, historically boosting stock prices during such events.
Investor conferences are critical for visibility; strong presentations can enhance market sentiment.
Immediate interest and potential price movements expected around the conference dates.
WASHINGTON, Aug. 28, 2025 /PRNewswire/ -- Vanda Pharmaceuticals Inc. (Vanda) (NASDAQ:VNDA) today announced that the company will participate in the following upcoming investor conferences in September 2025:
The Cantor Global Healthcare Conference 2025 in New York City on Wednesday, September 3, 2025. A corporate presentation is scheduled for 3:55 p.m. Eastern Time.
The 2025 Wells Fargo Healthcare Conference in Boston on Thursday, September 4, 2025. A corporate presentation is scheduled for 4:30 p.m. Eastern Time.
The H.C. Wainwright Annual Global Investment Conference in New York City on Tuesday, September 9, 2025. A corporate presentation is scheduled for 8:30 a.m. Eastern Time.
The corporate presentations given at the Cantor, Wells Fargo and H.C. Wainwright conferences may be accessed live on Vanda's corporate website, www.vandapharma.com. Investors should click on the Investors tab and follow the link under Recent Events. Investors are advised to go to the conference website at least 15 minutes early to register, download, and install any necessary software or presentations. A link to the archived conference will be available on Vanda's website for a period of approximately 30 days.
About Vanda Pharmaceuticals Inc.
Vanda is a leading global biopharmaceutical company focused on the development and commercialization of innovative therapies to address high unmet medical needs and improve the lives of patients. For more on Vanda Pharmaceuticals Inc., please visit www.vandapharma.com and follow us on X @vandapharma.
Corporate Contact:
Kevin Moran
Senior Vice President, Chief Financial Officer and Treasurer
Vanda Pharmaceuticals Inc.
202-734-3400
pr@vandapharma.com
Jim Golden / Jack Kelleher / Dan Moore
Collected Strategies
VANDA-CS@collectedstrategies.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/vanda-pharmaceuticals-announces-participation-at-september-2025-investor-conferences-302541540.html
SOURCE Vanda Pharmaceuticals Inc.